Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Microvi Biotechnologies is a commercial-stage industrial biotechnology company specializing in next-generation biocatalytic processes for the water, wastewater, and chemical industries. The company's core technology, Micro-Niche Engineering (MNE), utilizes a proprietary method of immobilizing specialized microorganisms within a synthetic micro-environment to significantly enhance metabolic activity and process stability. This platform allows for the efficient removal of contaminants such as nitrates, perchlorate, and 1,4-dioxane from water supplies with minimal waste production and a reduced physical footprint. Beyond environmental applications, Microvi is expanding its platform into the production of bio-based chemicals and fuels, offering a sustainable alternative to traditional thermochemical manufacturing. The company's solutions are designed to be scalable, cost-effective, and easily integrated into existing infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Microvi Biotechnologies.